Researchers explored the relationship between TNF inhibitor exposure and depression among patients with ankylosing spondylitis.
“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most ...
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...
Patients with very early axial spondyloarthritis (axSpA) who started a first TNF inhibitor within 1 year of the onset of back pain did not have better 1-year clinical outcomes or longer drug retention ...
Please provide your email address to receive an email when new articles are posted on . Patients treated with TNF inhibitors had respiratory hospitalization and mortality rates similar to patients on ...
A specific class of anti-inflammatory drugs can help children avoid a debilitating complication of Crohn's disease. A new study published recently in the journal Gut shows children with Crohn's who ...
A comprehensive meta-analysis of 18 studies, involving more than 1 million patients with autoimmune diseases, has revealed a 36% higher risk of central nervous system (CNS) inflammatory diseases in ...
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results